Bioforce Nanosciences Holdings, Inc.
BFNH· OTC
BFNHBioforce Nanosciences Holdings, Inc.
Filed May 9, 2023 · 10-Q · 39 days after period end · 0001091818-23-000071
| Metric | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|
| Net Income | -$130.01K | -$132.41K | -$145.08K | -$158.04M |
| EPS Diluted | $0.00 | — | $0.00 | -$10.35 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bioforce Nanosciences Holdings, Inc. · CIK 1310488 · Engraved from SEC EDGAR
ended Mar 31, 2023 · filed May 9, 2023 · 39 d after period end
